CSC treatment for pancreatic cancer
OncoMed Pharma (OMED) Announces Completion of Demcizumab Phase 2 Enrollment as Pancreatic Cancer Treatment September 1, 2016 8:04 AM EDT OncoMed Pharmaceuticals Inc. (Nasdaq: OMED) announced […]
CSC treatment for pancreatic cancer Read More »
